Avalo Therapeutics, Inc. - AVTX

About Gravity Analytica
Recent News
- 05.22.2026 - Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
- 05.13.2026 - Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates
Recent Filings
- 05.19.2026 - 4 Statement of changes in beneficial ownership of securities
- 05.15.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
- 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.15.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
- 05.14.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]